Securin promotes the identification of favourable outcome in invasive breast cancer.
BACKGROUND
Securin is a recently recognised oncogene with multiple known functions in initiation, progression and cell cycle regulation in several malignant diseases, including breast carcinoma.


METHODS
In this paper, the prognostic value of securin is evaluated by immunohistochemistry in 310 patients diagnosed with invasive breast cancer during a mammographic screening programme in Central Finland. All patients were directed to modern surgical and oncological treatments and were followed up for a maximum of 20 years.


RESULTS
Our results suggest that securin immunopositivity is an independent prognosticator of invasive breast cancer. In our study, securin predicted breast cancer-specific survival among all cases of invasive breast cancer and subgroups divided according to histological type, Ki-67 proliferation status and tumour size. Especially in a multivariate analysis standardised for axillary lymph node status, patient's age and tumour size at the time of diagnosis, securin immunopositivity indicated a 13.1-fold risk of breast cancer death (P=0.024) among invasive ductal breast carcinomas with low Ki-67 positivity.


CONCLUSIONS
Our present and previous results suggest that securin could be useful in clinical pathology to intensify the power of the established prognosticators of invasive breast cancer and, especially, to assist in identifying patients with a more favourable outcome than that indicated by Ki-67 alone.
Talvinen
K
K
Department of Pathology, University of Turku, Kiinamyllynkatu 10, Turku FIN-20520, Finland. kattal@utu.fi
Karra
H
H
Hurme
S
S
Nykänen
M
M
Nieminen
A
A
Anttinen
J
J
Kuopio
T
T
Kronqvist
P
P
D000368:Aged; D001943:Breast Neoplasms / Q000737:chemistry / Q000401:mortality* / Q000473:pathology; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis*; D011379:Prognosis; D064249:Securin
D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D064249:Securin; C578002:pituitary tumor-transforming protein 1, human
J Clin Endocrinol Metab. 2005 Jun;90(6):3715-23
15769981
Br J Cancer. 2008 Jul 22;99(2):335-40
18594525
Cell. 2005 Mar 25;120(6):739-46
15797376
Clin Med Res. 2006 Jun;4(2):130-7
16809406
Am J Pathol. 2001 Apr;158(4):1245-51
11290542
Am J Clin Pathol. 1998 Jul;110(1):24-31
9661919
Anticancer Res. 2006 Mar-Apr;26(2A):1253-9
16619532
Oncogene. 1999 Sep 23;18(39):5473-6
10498901
Br J Cancer. 1989 Jun;59(6):943-7
2472168
Histopathology. 2008 Dec;53(6):642-9
19076680
J Pathol. 1999 Nov;189(3):309-18
10547591
Mol Endocrinol. 2000 Aug;14(8):1137-46
10935539
Pathobiology. 2008;75(2):95-103
18544964
J Surg Res. 2005 Nov;129(1):142-6
15936773
Nat Genet. 2003 Jan;33(1):49-54
12469122
Nat Med. 1998 Jul;4(7):844-7
9662379
J Natl Cancer Inst. 1999 Feb 3;91(3):271-8
10037106
Curr Biol. 2002 Aug 20;12(16):1368-78
12194817
Nat Rev Cancer. 2005 Oct;5(10):773-85
16195750
Oncol Rep. 2006 Jun;15(6):1569-74
16685397
J Pathol. 2000 Dec;192(4):549-53
11113875
J Clin Endocrinol Metab. 2003 May;88(5):2341-7
12727994
Hum Pathol. 1995 Oct;26(10):1086-92
7557941
Cancer Res. 2008 May 1;68(9):3214-24
18451147
World J Gastroenterol. 2005 Jun 7;11(21):3245-9
15929175
J Mol Endocrinol. 2009 Feb;42(2):87-103
18984771
Blood. 2003 Jan 15;101(2):681-9
12393683
Breast Cancer Res. 2008;10(2):R26
18371194
Clin Endocrinol (Oxf). 2006 Oct;65(4):536-43
16984249
J Exp Med. 1981 Dec 1;154(6):1899-909
6172535
J Cell Biol. 2002 Jun 24;157(7):1125-37
12070128
Cell. 1998 Jun 12;93(6):1067-76
9635435
Mod Pathol. 2009 Feb;22(2):273-81
18997736
Breast Cancer Res Treat. 2009 May;115(2):241-54
18665447
Oncogene. 2004 Mar 15;23(11):2016-27
15021889
Cancer. 1993 Jun 15;71(12):3926-31
8508358
Jpn J Clin Oncol. 2002 Jul;32(7):233-7
12324572
Mol Cancer Ther. 2005 Apr;4(4):562-8
15827329
Oncogene. 1998 Oct 29;17(17):2187-93
9811450
Histopathology. 1991 Nov;19(5):403-10
1757079
Pathology. 2009 Jan;41(1):77-88
19089743
Hum Pathol. 2001 Mar;32(3):311-9
11274641
Anal Cell Pathol. 1989 Feb;1(1):25-39
2488698
Endocr Relat Cancer. 2008 Sep;15(3):721-43
18753362
J Clin Invest. 2002 Jan;109(2):277-83
11805140
Blood. 1997 Jul 1;90(1):226-33
9207457
World J Gastroenterol. 2004 Feb 15;10(4):481-3
14966902
Mod Pathol. 2005 Jul;18(7):985-90
15846392
N Engl J Med. 2002 Dec 19;347(25):1999-2009
12490681
Mol Pharmacol. 2006 Jan;69(1):154-64
16219911
Histol Histopathol. 2007 Feb;22(2):219-26
17149695
Breast. 2004 Feb;13(1):80-1
14759723
Breast. 2008 Aug;17(4):323-34
18455396
Endocr Rev. 2007 Apr;28(2):165-86
17325339